Thus, these PCa risk-associated H3K27Ac sites may be involved in “enhancer adoption” by the promoters of the KCNN3 and KRT78 genes in the cells deleted for the PCa risk-associated CTCF sites. The gene discussed is CTCF; the disease is posterior cortical atrophy.